Effect of n-scCO2 on crystalline to amorphous conversion of carbamazepine

International Journal of Pharmaceutics

Volumn 333, Issue 1-2, 2007, Pages 152-161

  Ugaonkar, Shweta ^a   Nunes, Anthony C ^a   Needham, Thomas E ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Amorphous; Carbamazepine; Initial release; n scCO2; PVP10k; Ratio of ratios (ROR)

Indexed keywords

CARBAMAZEPINE; CARBON DIOXIDE; CARBOXYMETHYLCELLULOSE; NEAR SUPERCRITICAL CARBON DIOXIDE; POVIDONE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG MIXTURE; DRUG SOLUBILITY; MATHEMATICAL PARAMETERS; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TECHNIQUE; X RAY DIFFRACTION;

ANTICONVULSANTS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; CARBON DIOXIDE; CARBOXYMETHYLCELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, SUPERCRITICAL FLUID; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIFFUSION; DRUG CARRIERS; MODELS, CHEMICAL; MOLECULAR WEIGHT; PARTICLE SIZE; PHASE TRANSITION; POVIDONE; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNOLOGY, PHARMACEUTICAL; TRANSITION TEMPERATURE;

EID: 33847103562     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.12.010     Document Type: Article

References (28)

1. Behme R., and Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 80 (1990) 986-990
2. Cansell F., Aynmonier C., and Loppinet-Serani A. Review on materials science and supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 331-340
3. Craig D.Q.M. Review-the mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
4. Craig D., Royall P., Kett V., and Hopton M. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharm. 179 (1999) 179-207
5. Dobbs J.M., Wong J.M., and Johnston K.P. Non polar co-solvents for solubility enhancement in supercritical fluid carbon dioxide. J. Chem. Eng. Data 31 (1986) 303-308
6. Doshi D.H., Ravis W.R., and Betageri G.V. Carbamazepine and polyethylene glycol solid dispersion preparation, in vitro dissolution, and characterization. Drug Dev. Ind. Pharm. 23 (1997) 1167-1176
7. Han J., Zhang Y., Grant G., and Suryanarayanan R. In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine. Pharm. Dev. Tech. 5 (2000) 257-266
8. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
9. Hancock B.C., Shamblin S., and Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 12 (1995) 799-806
10. Kaneniwa N., Ichikawa J., Yamaguchi T., Hayashi K., Watari N., and Sumi M. Dissolution behaviour of carbamazepine polymorphs. Yakugaku Zasshi 107 (1987) 808-813
11. Kazarian S.G. Supercritical Fluid Impregnation of Polymers for Drug Delivery. Supercritical Fluid Technology for Drug Product Development vol. 138 (2004), Marcel and Dekker p. 343
12. Kazarian S.G., and Martirosyan G.G. Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP. Int. J. Pharm. 232 (2002) 81-90
13. Kearney A.S., Gabriel D.L., Mehta S.C., and Radebaugh G.W. Effect of polyvinylpyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory CI-987. Int. J. Pharm. 104 (1994) 169-174
14. Kobayashi Y., Ito S., Itai S., and Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int. J. Pharm. 193 (2000) 137-146
15. Krahn F.U., and Mielck J. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm. Acta Helv. 62 (1987) 247-254
16. Lang M., Kampf J.W., and Matzger A.J. Form IV of carbamazepine. J. Pharm. Sci. 91 (2002) 1186-1190
17. Lo{combining double acute accent}benberg R., and Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics, classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50 (2000) 3-12
18. Moneghini M., Kikic I., Voinovich D., Perissutti B., and Filipović-Grčić. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbondioxide: preparation, characterization, and in vitro dissolution. Int. J. Pharm. 222 (2001) 129-138
19. Mukhopadhyay, M., 2004. Phase equilibrium in solid-liquid-supercritical fluid systems supercritical fluid technology for drug product development. 32, 27
20. Nair R., Nyamweya N., Gönen, Martínez-Miranda, and Hoag S.W. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int. J. Pharm. 225 (2001) 83-96
21. Nair R., Gonen S., and Hoag S.W. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int. J. Pharm. 240 (2002) 11-22
22. 2. J. Phys. Chem. 100 (1996) 15581-15587
23. Sethia S., and Squillante E. Solid dispersion of carbamazepine in PVP K-30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272 (2004) 1-10
24. Simonelli, A.P., Mehta, S.C., Higuchi, W.I., 1976. Dissolution rates of high energy sulfathiazole-povidone coprecipitates. II. Characterization of form of drug controlling its dissolution rate via solubility studies. 65, 355-361.
25. Taylor J.R. An Introduction to Error Analysis: The Study of Uncertainties in Physical Measurements (1982), Oxford University Press Chapter 3, p. 57
26. Thumsi, S.G., 2004. Investigating the effect of supercritical fluid in characterization of nifedipine and possible improvement of dissolution. Master of Science Thesis, University of Rhode Island, USA, p. 123.
27. Warren B.E. X-ray Diffraction (1969), Addison Wesley publication pp. 331-332
28. Yoshioka M., Hancock B.C., and Zografi G. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J. Pharm. Sci. 84 (1995) 983-986